235 related articles for article (PubMed ID: 11845047)
1. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
Buecher B; Heymann MF; Blottière HM
Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
[No Abstract] [Full Text] [Related]
2. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
[TBL] [Abstract][Full Text] [Related]
3. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
[TBL] [Abstract][Full Text] [Related]
4. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
5. [Colorectal cancer and inhibition of cyclooxygenase-2].
Geissler M; Mohr L; Blum HE
Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
[No Abstract] [Full Text] [Related]
6. COX-2 inhibition and prevention of cancer.
Giercksky KE
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):821-33. PubMed ID: 11566043
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
9. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
10. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
Florent C; Meary N
Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W; Rie C; Grothey A; Schmoll HJ
J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).
Poon R; Smits R; Li C; Jagmohan-Changur S; Kong M; Cheon S; Yu C; Fodde R; Alman BA
Oncogene; 2001 Jan; 20(4):451-60. PubMed ID: 11313976
[TBL] [Abstract][Full Text] [Related]
13. Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells.
Hsi LC; Baek SJ; Eling TE
Exp Cell Res; 2000 May; 256(2):563-70. PubMed ID: 10772828
[TBL] [Abstract][Full Text] [Related]
14. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
[TBL] [Abstract][Full Text] [Related]
15. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Suppl 2():S89-98. PubMed ID: 15899632
[TBL] [Abstract][Full Text] [Related]
16. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
Bottone FG; Martinez JM; Alston-Mills B; Eling TE
Carcinogenesis; 2004 Mar; 25(3):349-57. PubMed ID: 14633654
[TBL] [Abstract][Full Text] [Related]
17. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level.
Hsi LC; Angerman-Stewart J; Eling TE
Carcinogenesis; 1999 Nov; 20(11):2045-9. PubMed ID: 10545404
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
Kleibeuker JH; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2203-7. PubMed ID: 14640056
[TBL] [Abstract][Full Text] [Related]
19. COX-2 inhibitors cut risk of colon polyps.
Health News; 2000 Aug; 6(8):6. PubMed ID: 10948872
[No Abstract] [Full Text] [Related]
20. [Genetics of colon carcinogenesis].
Sasaki S; Watanabe T; Nagawa H
Nihon Rinsho; 2003 Sep; 61 Suppl 7():72-4. PubMed ID: 14574858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
